Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
Submitted: January 10, 2017
Accepted: January 10, 2017
Published: December 30, 2016
Accepted: January 10, 2017
Abstract Views: 2270
PDF: 1187
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Pepe, P., Cimino, S., Garufi, A., Priolo, G., Russo, G. I., Giardina, R., Reale, G., Barbera, M., Panella, P., Pennisi, M., & Morgia, G. (2016). Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy. Archivio Italiano Di Urologia E Andrologia, 88(4), 300–303. https://doi.org/10.4081/aiua.2016.4.300
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.